Meeting of the National Vaccine Advisory Committee, 2107-2108 [2015-00519]

Download as PDF Federal Register / Vol. 80, No. 10 / Thursday, January 15, 2015 / Notices 2107 EARLY TERMINATIONS GRANTED—Continued [December 1, 2014 thru December 31, 2014] 12/30/2014 20150118 ...... G Siemens Aktiengesellschaft; Dresser-Rand Group Inc.; Siemens Aktiengesellschaft. 12/31/2014 20150360 20150368 20150369 20150374 20150375 20150379 20150381 20150385 ...... ...... ...... ...... ...... ...... ...... ...... G G G G G G G G Aviation Industry Corporation of China; Greenbriar Equity Fund II, L.P.; Aviation Industry Corporation of China. Deutsche Telekom AG; Paul G. Allen; Deutsche Telekom AG. BlackRock, Inc.; BlackRock Kelso Capital Advisors LLC; BlackRock, Inc. RenaissanceRe Holdings Ltd.; Platinum Underwriters Holdings, Ltd.; RenaissanceRe Holdings Ltd. Gilles Martin; Bain Capital Venture Fund 2009, L.P.; Gilles Martin. AMN Healthcare Services, Inc.; Welsh, Carson Anderson & Stowe IX, L.P.; AMN Healthcare Services, Inc. Wind Point Partners VI, L.P.; The Dow Chemical Company; Wind Point Partners VI, L.P. Dominion Resources, Inc; SCANA Corporation; Dominion Resources, Inc. FOR FURTHER INFORMATION CONTACT: By direction of the Commission. Donald Clark, Secretary. [FR Doc. 2015–00515 Filed 1–14–15; 8:45 am] BILLING CODE 6750–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the Advisory Committee on Minority Health Office of the Secretary, Office of Minority Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice of meeting. AGENCY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (DHHS) is hereby giving notice that the Advisory Committee on Minority Health (ACMH) will hold a meeting. This meeting will be open to the public. Preregistration is required for both public attendance and comment. Any individual who wishes to attend the meetings and/or participate in the public comment session should email OMH-ACMH@ hhs.gov. SUMMARY: The meeting will be held on Thursday, February 12, 2015, from 9:00 a.m. to 5:00 p.m. and on Friday, February 13, 2015, from 9:00 a.m. to 1:00 p.m. ADDRESSES: The meeting will be held at the Hubert H. Humphrey Building, 200 Independence Avenue SW., Washington, DC 20201, Room 505A. rljohnson on DSK3VPTVN1PROD with NOTICES DATES: VerDate Sep<11>2014 14:13 Jan 14, 2015 Jkt 235001 Dr. Rashida Dorsey, Designated Federal Officer, ACMH; OMH-ACMH@hhs.gov, Tower Building, 1101 Wootton Parkway, Suite 600, Rockville, Maryland 20852. Phone: 240–453–8222, Fax: 240–453–8223. SUPPLEMENTARY INFORMATION: In accordance with Public Law 105–392, the ACMH was established to provide advice to the Deputy Assistant Secretary for Minority Health in improving the health of each racial and ethnic minority group and on the development of goals and specific program activities of the Office of Minority Health. Topics to be discussed during these meetings will include strategies to improve the health of racial and ethnic minority populations through the development of health policies and programs that will help eliminate health disparities, as well as other related issues. Public attendance at this meeting is limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the designated contact person at least fourteen (14) business days prior to the meeting. Members of the public will have an opportunity to provide comments at the meeting. Public comments will be limited to three minutes per speaker. Individuals who would like to submit written statements should mail or fax their comments to the Office of Minority Health at least seven (7) business days prior to the meeting. Any members of the public who wish to have printed material distributed to ACMH committee members should submit their materials to the Designated Federal Officer, ACMH, Tower Building, 1101 Wootton Parkway, Suite 600, Rockville, Maryland 20852, prior to close of business Thursday, February 5, 2015. FOR FURTHER INFORMATION CONTACT: Renee Chapman, Contact Representative, or Theresa Kingsberry, Legal Assistant, Federal Trade Commission, Premerger Notification Office, Bureau of Competition, Room CC–5301, Washington, DC 20024, (202) 326–3100. PO 00000 Frm 00016 Fmt 4703 Sfmt 4703 Dated: January 6, 2015. Rashida Dorsey, Designated Federal Officer, ACMH, Office of Minority Health, U.S. Department of Health and Human Services. [FR Doc. 2015–00520 Filed 1–14–15; 8:45 am] BILLING CODE 4150–29–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the National Vaccine Advisory Committee National Vaccine Program Office, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that the National Vaccine Advisory Committee (NVAC) will hold a meeting February 10–11, 2015. The meeting is open to the public. However, preregistration is required for both public attendance and public comment. Individuals who wish to attend the meeting and/or participate in the public comment session should register at https://www.hhs.gov/nvpo/nvac. Participants may also register by emailing nvpo@hhs.gov or by calling 202–690–5566 to provide your name, organization, and email address. DATES: The meeting will be held on February 10–11, 2015. The meeting times and agenda will be posted on the NVAC Web site at https://www.hhs.gov/ nvpo/nvac as soon they become available. ADDRESSES: U.S. Department of Health and Human Services, Hubert H. Humphrey Building, Great Hall, 200 Independence Avenue SW., Washington, DC 20201. SUMMARY: E:\FR\FM\15JAN1.SGM 15JAN1 2108 Federal Register / Vol. 80, No. 10 / Thursday, January 15, 2015 / Notices The meeting can also be accessed through a live webcast the day of the meeting. For more information, visit https://www.hhs.gov/nvpo/nvac/ meetings/upcomingmeetings/ index.html. FOR FURTHER INFORMATION CONTACT: National Vaccine Program Office, U.S. Department of Health and Human Services, Room 715–H, Hubert H. Humphrey Building, 200 Independence Avenue SW., Washington, DC 20201. Phone: (202) 690–5566; email: nvpo@ hhs.gov. Pursuant to Section 2101 of the Public Health Service Act (42 U.S.C. 300aa–1), the Secretary of Health and Human Services was mandated to establish the National Vaccine Program to achieve optimal prevention of human infectious diseases through immunization and to achieve optimal prevention against adverse reactions to vaccines. The NVAC was established to provide advice and make recommendations to the Director of the National Vaccine Program on matters related to the Program’s responsibilities. The Assistant Secretary for Health serves as Director of the National Vaccine Program. The topics planned for the February NVAC meeting will include a number of sessions addressing vaccine innovation. The NVAC will hear about current U.S. government-wide strategies to combat antimicrobial resistance followed by a panel discussion on the role vaccines (both existing and new) could play in those strategies. The Institute of Medicine will present their recently released report on the Strategic MultiAttribute Ranking Tool for Vaccines (SMART-Vaccines) software developed to support prioritization of new vaccine research and development. NVAC will then hear from beta-testers of the SMART-Vaccine software about their experience and possible uses for the tool going forward. NVAC will also discuss the on-going efforts to better understand and overcome the barriers to sharing immunization registry data between states. NVAC will preview both the National Vaccine Annual Report and the National Adult Immunization Plan. In addition, the Vaccine Confidence/Acceptance and the NVAC HPV working groups will present their draft report and draft recommendations for NVAC consideration and discussion. Finally, the NVAC Maternal Immunization and the NVAC Mid-Course Review Working Groups will provide an update on their progress. The meeting agenda will be posted on the NVAC Web site: https:// rljohnson on DSK3VPTVN1PROD with NOTICES SUPPLEMENTARY INFORMATION: VerDate Sep<11>2014 14:13 Jan 14, 2015 Jkt 235001 www.hhs.gov/nvpo/nvac prior to the meeting. Public attendance at the meeting is limited to the available space. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the National Vaccine Program Office at the address/phone listed above at least one week prior to the meeting. For those unable to attend in person, a live webcast will be available. More information on registration and accessing the webcast can be found at https://www.hhs.gov/nvpo/nvac/ meetings/upcomingmeetings/ index.html. Members of the public will have the opportunity to provide comments at the NVAC meeting during the public comment periods designated on the agenda. Individuals who would like to submit written statements should email their comments to the National Vaccine Program Office (nvpo@hhs.gov) at least five business days prior to the meeting. Dated: 12 January 2015. Bruce Gellin, Executive Secretary, National Vaccine Advisory Committee, Deputy Assistant Secretary for Health, Director, National Vaccine Program Office. [FR Doc. 2015–00519 Filed 1–14–15; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Solicitation of Nominations for Appointment to the Advisory Committee on Minority Health Office of Minority Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice for solicitation of Advisory Committee on Minority Health members. AGENCY: Authority: 42 U.S.C. 300u–6, Section 1707 of the Public Health Service Act, as amended. The Advisory Committee is governed by provisions of Public Law 92–463, as amended (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of advisory committees. The Department of Health and Human Services (HHS), Office of Minority Health (OMH), is seeking nominations of qualified candidates to be considered for appointment as a member of the Advisory Committee on Minority Health (hereafter referred to as the ‘‘Committee or ACMH’’). In accordance with Public Law 105–392, the Committee provides advice to the Deputy Assistant Secretary for Minority SUMMARY: PO 00000 Frm 00017 Fmt 4703 Sfmt 4703 Health on improving the health of racial and ethnic minority groups, and on the development of goals and specific program activities of OMH designed to improve the health status and outcomes of racial and ethnic minorities. Nominations of qualified candidates are being sought to fill vacancies on the Committee. DATES: Nominations for membership on the Committee must be received no later than 5:00 p.m. EST on April 15, 2015, at the address listed below. ADDRESSES: All nominations should be mailed to Dr. Rashida Dorsey, Designated Federal Officer, Advisory Committee on Minority Health, Office of Minority Health, Department of Health and Human Services, 1101 Wootton Parkway, Suite 600, Rockville, MD 20852. FOR FURTHER INFORMATION CONTACT: Dr. Rashida Dorsey, Designated Federal Officer, Advisory Committee on Minority Health, Office of Minority Health, Department of Health and Human Services, Tower Building, 1101 Wootton Parkway, Suite 600, Rockville, Maryland 20852. Phone: 240–453–8222; fax: 240–453–8223. A copy of the ACMH charter and list of the current membership can be obtained by contacting Dr. Dorsey or by accessing the Web site managed by OMH at www.minorityhealth.hhs.gov. Information about ACMH activities can be found on the OMH Web site under the heading About OMH. SUPPLEMENTARY INFORMATION: Pursuant to Public Law 105–392, the Secretary of Health and Human Services established the ACMH. The Committee provides advice to the Deputy Assistant Secretary for Minority Health in carrying out the duties stipulated under Public Law 105– 392. This includes providing advice on improving the health of racial and ethnic minority populations and in the development of goals and specific program activities of OMH, which are to: (1) Establish short-range and longrange goals and objectives and coordinate all other activities within the Public Health Service that relate to disease prevention, health promotion, service delivery, and research impacting racial and ethnic minority populations; (2) enter into interagency agreements with other agencies of the Public Health Service; (3) support research, demonstrations, and evaluations to test new and innovative models; (4) increase knowledge and understanding of health risk factors; (5) develop mechanisms that support better information dissemination, E:\FR\FM\15JAN1.SGM 15JAN1

Agencies

[Federal Register Volume 80, Number 10 (Thursday, January 15, 2015)]
[Notices]
[Pages 2107-2108]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-00519]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee

AGENCY: National Vaccine Program Office, Office of the Assistant 
Secretary for Health, Office of the Secretary, Department of Health and 
Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that the National Vaccine Advisory Committee (NVAC) will hold a meeting 
February 10-11, 2015. The meeting is open to the public. However, pre-
registration is required for both public attendance and public comment. 
Individuals who wish to attend the meeting and/or participate in the 
public comment session should register at https://www.hhs.gov/nvpo/nvac. 
Participants may also register by emailing nvpo@hhs.gov or by calling 
202-690-5566 to provide your name, organization, and email address.

DATES: The meeting will be held on February 10-11, 2015. The meeting 
times and agenda will be posted on the NVAC Web site at https://www.hhs.gov/nvpo/nvac as soon they become available.

ADDRESSES: U.S. Department of Health and Human Services, Hubert H. 
Humphrey Building, Great Hall, 200 Independence Avenue SW., Washington, 
DC 20201.

[[Page 2108]]

    The meeting can also be accessed through a live webcast the day of 
the meeting. For more information, visit https://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/.

FOR FURTHER INFORMATION CONTACT: National Vaccine Program Office, U.S. 
Department of Health and Human Services, Room 715-H, Hubert H. Humphrey 
Building, 200 Independence Avenue SW., Washington, DC 20201. Phone: 
(202) 690-5566; email: nvpo@hhs.gov.

SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public 
Health Service Act (42 U.S.C. 300aa-1), the Secretary of Health and 
Human Services was mandated to establish the National Vaccine Program 
to achieve optimal prevention of human infectious diseases through 
immunization and to achieve optimal prevention against adverse 
reactions to vaccines. The NVAC was established to provide advice and 
make recommendations to the Director of the National Vaccine Program on 
matters related to the Program's responsibilities. The Assistant 
Secretary for Health serves as Director of the National Vaccine 
Program.
    The topics planned for the February NVAC meeting will include a 
number of sessions addressing vaccine innovation. The NVAC will hear 
about current U.S. government-wide strategies to combat antimicrobial 
resistance followed by a panel discussion on the role vaccines (both 
existing and new) could play in those strategies. The Institute of 
Medicine will present their recently released report on the Strategic 
Multi-Attribute Ranking Tool for Vaccines (SMART-Vaccines) software 
developed to support prioritization of new vaccine research and 
development. NVAC will then hear from beta-testers of the SMART-Vaccine 
software about their experience and possible uses for the tool going 
forward. NVAC will also discuss the on-going efforts to better 
understand and overcome the barriers to sharing immunization registry 
data between states.
    NVAC will preview both the National Vaccine Annual Report and the 
National Adult Immunization Plan. In addition, the Vaccine Confidence/
Acceptance and the NVAC HPV working groups will present their draft 
report and draft recommendations for NVAC consideration and discussion. 
Finally, the NVAC Maternal Immunization and the NVAC Mid-Course Review 
Working Groups will provide an update on their progress. The meeting 
agenda will be posted on the NVAC Web site: https://www.hhs.gov/nvpo/nvac prior to the meeting.
    Public attendance at the meeting is limited to the available space. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the National Vaccine Program Office at the address/phone listed 
above at least one week prior to the meeting. For those unable to 
attend in person, a live webcast will be available. More information on 
registration and accessing the webcast can be found at https://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/.
    Members of the public will have the opportunity to provide comments 
at the NVAC meeting during the public comment periods designated on the 
agenda. Individuals who would like to submit written statements should 
email their comments to the National Vaccine Program Office 
(nvpo@hhs.gov) at least five business days prior to the meeting.

    Dated: 12 January 2015.
Bruce Gellin,
Executive Secretary, National Vaccine Advisory Committee, Deputy 
Assistant Secretary for Health, Director, National Vaccine Program 
Office.
[FR Doc. 2015-00519 Filed 1-14-15; 8:45 am]
BILLING CODE 4150-44-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.